Pablo Albasanz-García/LinkedIn
Jan 14, 2026, 11:26
Pablo Albasanz-García and Colleagues on Anticancer Treatment-Induced Arterial and Venous Thrombosis
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Mechanisms of anticancer treatment-induced arterial and venous thrombosis
This narrative review explores how cancer therapies trigger blood clots through coagulation activation, vascular damage, tumor cell death materials, and inflammation—crucial for developing better thrombosis prevention strategies.
Authors: Pablo Albasanz-García, Mark Ward, Lucy Norris
Check out this article.”
Article: Mechanisms of anticancer treatment-induced arterial and venous thrombosis
Authors: Pablo Albasanz-García, Mark P. Ward, Lucy A. Norris
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 17, 2026, 09:05Addressing the Hidden Burden of Bleeding Disorders in Women – Hemophilia Society Mumbai Chapter
-
Oct 17, 2026, 08:49Maria Magnusson: Karolinska Experts Explore Gene Therapy in Sickle Cell Disease and Hemophilia
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026